Skip to main content
. 2025 Oct 7;17(19):3251. doi: 10.3390/cancers17193251
BCLC Barcelona Clinic Liver Cancer
CP Child-Pugh
CPN Complete pathological necrosis
CRCLM Colorectal cancer liver metastases
ECOG Eastern Cooperative Oncology Group
FDA Food and Drug Administration
HCC Hepatocellular carcinoma
mRECIST Modified Response Evaluation Criteria in Solid Tumors
MWA Microwave ablation
OS Overall survival
PFS Progression-free survival
PVTT Portal vein tumor thrombosis
RCT Randomized controlled trial
RFA Radiofrequency ablation
RADSAG Radiation segmentectomy
TACE Transarterial chemoembolization
TARE Transarterial radioembolization